Treatment for emerging viruses: Convalescent plasma and COVID-19.
Transfus Apher Sci. 2020 Jun;59(3):102790. doi: 10.1016/j.transci.2020.102790. Epub 2020 Apr 20.
Transfus Apher Sci. 2020.
PMID: 32345485
Free PMC article.
Review.
This convalescent plasma therapy is of particular interest when a vaccine or specific therapy is not yet available for emerging viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19 …
This convalescent plasma therapy is of particular interest when a vaccine or specific therapy is not yet available for emergin …